TheraBionic GmbH

We are a pioneering medical device company focused on transforming the lives of patients with difficult to treat cancers by applying our discoveries in bioelectromagnetics to targeted treatment of cancer. Our patient-based research using low and safe radiofrequency electromagnetic fields has led to the discovery of tumor specific modulation frequencies, which effectively block the growth of tumor cells without altering non-tumor cells. We have developed the TheraBionic P1 medical device, a portable device for home use. Our goal is to expand the use of the TheraBionic P1 in several other indications such breast cancer, prostate cancer, pancreatic cancer, ovarian cancer, cholangiocarcinoma, brain tumors. The tumor-specific modulation frequencies can also be used for early diagnosis of cancer.